HOME >> BIOLOGY >> NEWS
Small trial shows daclizumab add-on therapy improves MS outcome

rating scale and in a test of hand function. The clinical improvement was unexpected in such a small trial, since a larger number of patients is usually required to show clinical effects. One patient with extremely high inflammation activity responded initially to daclizumab but, as disease activity returned, was given higher doses of the antibody and was excluded from final analysis.

"There is great interest now in new approaches and new therapies for a disorder about which we know too little and have only moderately effective therapies," said Dr. Martin. "The combined therapy was well tolerated by all patients, with side effects that were either mild or clearly not caused by daclizumab." He said the therapy limits the activity of T-cells that attack the myelin coating around the nerves, without shutting down the entire immune system.

"While these results are preliminary, this discovery offers hope for thousands of patients with certain forms of MS. Findings like this are helping us to better understand how this disease affects the immune system, which offers hope for all MS patients," said Story C. Landis, Ph.D., NINDS director.

Further studies are needed to confirm the extent of the clinical benefit of daclizumab on typical MS patients and determine whether daclizumab is effective as a stand-alone therapy.

The study was a collaboration between the NINDS and its sister agency, the National Cancer Institute (NCI). Thomas Waldmann, M.D., chief of the metabolism branch for NCI's Center for Cancer Research, developed the antibody used in the trial.

Daclizumab (trade name Zenapax) received FDA approval in 1997 for use in kidney transplantation.


'"/>

Contact: Paul Girolami
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
24-May-2004


Page: 1 2

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small RNA surmounts large cancer problem
4. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
5. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2019)... ... 30, 2019 , ... Join Julie Peacock, Vice President of ... Wednesday, June 19, 2019 at 1pm EDT where she will demonstrate how role-based ... and contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. ...
(Date:5/24/2019)... THE WOODLANDS, Texas (PRWEB) , ... May 24, 2019 , ... ... has been published and is now available on the company’s global website. , Crystallography ... focusing on single crystal X-ray diffraction. It serves the X-ray analysis community by presenting ...
(Date:5/22/2019)... ... May 22, 2019 , ... Leak Detection Associates (LDA), the ... the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce ... Ltd has been signed. The agreement will grant exclusive rights for IPP ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... LA JOLLA, Calif. (PRWEB) , ... May 14, 2019 , ... ... announces an office expansion, effectively doubling its space from 2,500 to 5,000 square feet. ... SneakPeek Early Gender DNA tests ,” says Gateway Genomics CEO, Chris Jacob. “The ...
(Date:5/2/2019)... ... April 30, 2019 , ... ... ISO 9001:2015 standard, REPROCELL USA Inc. has demonstrated its ability to provide ... USA Inc. aims to enhance customer satisfaction through the effective implementation of ...
(Date:4/25/2019)... Calif. (PRWEB) , ... April 23, 2019 , ... Frank is an albino, deaf Great ... did not want him due to his health issues. Despite his hearing impairment, he was ... Tom, and the two would play all day, every day. As the two grew, playtime ...
(Date:4/15/2019)... ... April 15, 2019 , ... Sirrus, ... a $2 million bench plant expansion to increase production of methylene malonate monomers ... design and construction of Sirrus’ full-scale production facility, which is scheduled to break ...
Breaking Biology Technology:
Cached News: